ID3.md
... ...
@@ -7,7 +7,7 @@ link-citations: true
7 7
8 8
## History
9 9
ID3 was first reported as mutated in BL in 2012 by Richter et al.[@richterRecurrentMutationID32012a]
10
-The existence of mutations in DLBCL were described in 2012 by Schmitz et al[@schmitzBurkittLymphomaPathogenesis2] and later in MZL by Spina et al.[@spinaGeneticsNodalMarginal2016b]
10
+The existence of mutations in DLBCL were described in 2012 by Schmitz et al[@schmitzBurkittLymphomaPathogenesis2012] and later in MZL by Spina et al.[@spinaGeneticsNodalMarginal2016b]
11 11
12 12
```mermaid
13 13
%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
... ...
@@ -22,9 +22,9 @@ The existence of mutations in DLBCL were described in 2012 by Schmitz et al[@sch
22 22
23 23
|Entity|Tier|Description |
24 24
|:------:|:----:|-----------------------------------------|
25
-|![BL](images/icons/BL_tier1.png) |1 | high-confidence BL gene [@richterRecurrentMutationID32012a]|
25
+|![BL](images/icons/BL_tier1.png) |1 | high-confidence BL gene [@richterRecurrentMutationID32012a]|
26 26
|![MZL](images/icons/MZL_tier1.png) |1 | high-confidence MZL gene [@spinaGeneticsNodalMarginal2016b]|
27
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 | Although recurrent, the relevance of mutations in DLBCL is tenuous [@schmitzBurkittLymphomaPathogenesis2012]|
27
+|![DLBCL](images/icons/DLBCL_tier2.png) |2 | Although recurrent, the relevance of mutations in DLBCL is tenuous[@schmitzBurkittLymphomaPathogenesis2012]|
28 28
29 29
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
30 30